Login / Signup

Development of pharmacogenomic algorithm to optimize nateglinide dose for the treatment of type 2 diabetes mellitus.

Shaik Mohammad NaushadTajamul HussainSalman A AlrokayanVijay Kumar Kutala
Published in: Pharmacological reports : PR (2022)
CYP2C9, SLCO1B1, and MTNR1B genotyping help in optimizing nateglinide therapy based on this algorithm and ensuring safety and efficacy.
Keyphrases
  • machine learning
  • deep learning
  • high throughput
  • genome wide
  • neural network
  • stem cells
  • dna methylation
  • smoking cessation